Green hydrogen: Perovskite oxide catalysts analysed in an X-ray beam
Schematische Ansicht der transformierten Schicht (hellgrau) auf dem LaNiO3 Perowskitfilm (grün), aufgewachsen auf einem Substrat (braun). Rechts ist die vergrößerte Seitenansicht der transformierten Oxyhydroxid-Schicht (mit Spindichte an den Ni-Plätzen) aus Simulationen dargestellt. © UDE/AG Pentcheva
The production of green hydrogen requires catalysts that control the process of splitting water into oxygen and hydrogen. However, the structure of the catalyst changes under electrical tension, which also influences the catalytic activity. A team from the universities of Duisburg-Essen and Twente has investigated at BESSY II and elsewhere how the transformation of surfaces in perovskite oxide catalysts controls the activity of the oxygen evolution reaction.
In a climate-neutral energy system of the future, the sun and wind will be the main sources of electricity. Some of the "green" electricity can be used for the electrolytic splitting of water to produce "green" hydrogen. Hydrogen is an efficient energy storage medium and a valuable raw material for industry. Catalysts are used in electrolysis to accelerate the desired reaction and make the process more efficient. Different catalysts are used for hydrogen separation than for oxygen evolution, but both are necessary.
Perovskite oxide catalysts: inexpensive and with great potential
An interdisciplinary and international group of scientists from the University of Essen-Duisburg, the University of Twente, Forschungszentrum Jülich and HZB has now investigated the class of perovskite oxide catalysts for the oxygen evolution reaction in detail. Perovskite oxide catalysts have been significantly further developed in recent years, they are inexpensive and have the potential for further increases in catalytic efficiency. However, within a short time, changes appear on the surfaces of these materials which reduce the catalytic effect.
Spectroscopy at BESSY II
For this reason, the group has now analysed the surface structure in particular and compared the experimental data with density functional calculations. And spectroscopic analyses at the X-ray source BESSY II were performed. "We were able to determine that a certain surface facet is significantly more active and at the same time more stable than others. X-ray analyses allow us to understand how to overcome the traditional trade-off between activity and stability," says HZB scientist Dr Marcel Risch. The results also show how certain surface facets transform and where, for example, hydrogen atoms (or protons) accumulate.
These insights into transformation processes and structural transformations and chemical processes on the different facets of the samples studied are valuable: they contribute to the knowledge-based design of materials as electrocatalysts. After all, electrocatalysts are the key to many applications in green chemistry.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. UhlAlexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.